Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 01:44PM ET
49.80
Dollar change
-0.70
Percentage change
-1.39
%
IndexRUT P/E116.84 EPS (ttm)0.43 Insider Own0.33% Shs Outstand54.30M Perf Week-5.15%
Market Cap2.70B Forward P/E13.62 EPS next Y3.65 Insider Trans-0.83% Shs Float54.12M Perf Month-4.42%
Income23.63M PEG- EPS next Q0.80 Inst Own100.02% Short Float4.37% Perf Quarter5.75%
Sales1.24B P/S2.18 EPS this Y19.51% Inst Trans-3.91% Short Ratio5.16 Perf Half Y-6.71%
Book/sh24.13 P/B2.06 EPS next Y9.22% ROA0.97% Short Interest2.36M Perf Year11.78%
Cash/sh12.28 P/C4.06 EPS next 5Y-4.60% ROE1.86% 52W Range43.15 - 64.47 Perf YTD-3.76%
Dividend Est.- P/FCF24.88 EPS past 5Y- ROI1.21% 52W High-22.77% Beta0.99
Dividend TTM- Quick Ratio2.87 Sales past 5Y1.30% Gross Margin68.16% 52W Low15.40% ATR (14)1.44
Dividend Ex-Date- Current Ratio3.37 EPS Y/Y TTM691.94% Oper. Margin11.09% RSI (14)40.34 Volatility1.90% 2.88%
Employees2900 Debt/Eq0.52 Sales Y/Y TTM10.69% Profit Margin1.91% Recom1.33 Target Price71.78
Option/ShortYes / Yes LT Debt/Eq0.49 EPS Q/Q545.21% Payout0.00% Rel Volume0.52 Prev Close50.50
Sales Surprise5.89% EPS Surprise25.58% Sales Q/Q11.19% EarningsOct 30 BMO Avg Volume458.01K Price49.80
SMA20-3.70% SMA50-4.59% SMA200-6.22% Trades Volume158,441 Change-1.39%
Date Action Analyst Rating Change Price Target Change
Oct-04-24Initiated Goldman Buy $65
Sep-17-24Upgrade Robert W. Baird Neutral → Outperform $55 → $66
Mar-20-24Reiterated Needham Buy
Feb-20-24Upgrade Mizuho Neutral → Buy $60 → $70
Sep-06-23Initiated HSBC Securities Hold $52
Jul-19-23Initiated Robert W. Baird Neutral $56
Apr-14-23Initiated Mizuho Neutral $48
Dec-21-22Initiated Barclays Equal Weight $62
Apr-06-22Initiated Wolfe Research Outperform $95
Feb-24-22Upgrade UBS Neutral → Buy $96
Dec-05-24 09:00AM
Nov-28-24 09:55AM
Nov-14-24 09:00AM
Nov-13-24 06:16AM
06:16AM
05:57AM Loading…
05:57AM
Nov-11-24 04:05PM
Nov-07-24 12:00PM
09:55AM
Nov-03-24 01:37PM
Oct-31-24 08:31AM
07:00AM
Oct-30-24 07:15AM
06:15AM
06:00AM
03:30PM Loading…
Oct-09-24 03:30PM
Oct-08-24 09:00AM
Sep-25-24 09:00AM
Sep-14-24 01:51AM
Sep-12-24 04:02PM
Aug-28-24 07:13PM
Aug-27-24 07:15PM
Aug-26-24 07:15PM
Aug-19-24 09:00AM
Aug-12-24 08:12PM
Jul-31-24 02:00PM
07:10AM
06:10AM
06:00AM
Jun-18-24 09:00AM
10:08PM Loading…
Jun-08-24 10:08PM
Jun-06-24 07:45PM
09:00AM
May-23-24 09:00AM
May-02-24 11:50AM
May-01-24 08:12PM
09:59AM
07:33AM
07:10AM
06:11AM
06:00AM
Apr-30-24 09:00AM
Apr-26-24 12:34PM
07:21AM
Apr-25-24 04:03PM
Apr-24-24 10:01AM
Mar-21-24 09:00AM
04:46AM
Mar-20-24 09:00AM
Mar-05-24 09:55PM
Mar-04-24 04:44PM
09:00AM
Feb-22-24 09:58AM
Feb-21-24 03:15PM
07:10AM
06:32AM
06:11AM
06:00AM
Feb-13-24 01:04PM
Feb-09-24 04:34AM
Feb-06-24 06:15AM
Feb-05-24 08:00AM
Jan-10-24 05:00AM
Jan-08-24 08:30AM
Jan-04-24 09:00AM
Dec-12-23 08:02PM
Dec-05-23 09:39AM
Nov-27-23 06:04AM
Nov-24-23 02:19PM
Nov-22-23 07:55PM
Nov-09-23 09:00AM
Nov-02-23 02:48PM
08:52AM
Nov-01-23 09:36AM
06:13AM
06:00AM
Oct-25-23 09:00AM
Oct-06-23 08:30AM
Sep-25-23 06:01PM
Sep-21-23 07:00AM
Sep-20-23 09:00AM
Sep-05-23 09:46AM
Aug-30-23 04:05PM
Aug-24-23 09:00AM
Jul-26-23 05:21PM
07:15AM
06:04AM
06:00AM
Jul-03-23 03:11PM
05:13AM
Jun-21-23 08:00PM
Jun-17-23 10:20AM
Jun-14-23 09:00AM
Jun-13-23 09:00AM
May-29-23 11:53AM
May-18-23 07:17AM
May-08-23 09:51AM
May-03-23 07:25AM
06:14AM
06:00AM
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bianchi FrancescoDirectorSep 11 '24Sale46.581,50069,8708,772Sep 13 04:13 PM
Bianchi FrancescoDirectorSep 11 '24Proposed Sale46.581,50069,870Sep 11 04:58 PM
WILVER PETER MDirectorJun 15 '24Option Exercise0.002,68004,317Jun 18 04:06 PM
Enxing Seng StacyDirectorJun 15 '24Option Exercise0.002,68009,330Jun 18 04:06 PM
Shvartsburg AlexCFOJun 15 '24Option Exercise0.001,576019,399Jun 18 04:06 PM
Bianchi FrancescoDirectorJun 15 '24Option Exercise0.002,680010,857Jun 18 04:06 PM
SCHERMERHORN TODD CDirectorJun 15 '24Option Exercise0.002,68006,643Jun 18 04:05 PM
O'Kane SharonDirectorJun 15 '24Option Exercise0.002,680010,754Jun 18 04:05 PM
Story BrookeDirectorJun 15 '24Option Exercise0.002,68004,060Jun 18 04:05 PM
Moore Daniel JeffreyDirectorJun 03 '24Option Exercise57.3956,6233,249,59484,157Jun 05 04:03 PM
Moore Daniel JeffreyDirectorJun 03 '24Sale60.1156,6233,403,69427,534Jun 05 04:03 PM
Bolton StephaniePresident, Global EpilepsyMar 30 '24Option Exercise0.007,744013,205Apr 02 09:22 PM
Hebbelinck TruiChief Human Resources OfficerMar 30 '24Option Exercise0.0011,779019,320Apr 02 09:21 PM
Shvartsburg AlexCFOMar 30 '24Option Exercise0.0014,752024,133Apr 02 09:20 PM
Hutchinson Michael DamonChief Legal OfficerMar 30 '24Option Exercise0.001,47802,828Apr 02 09:18 PM
KOZY WILLIAM AChairman and CEOFeb 29 '24Option Exercise0.0014,512032,333Mar 04 05:22 PM
Saia Andrea LynnDirectorDec 31 '23Option Exercise0.001,468011,113Jan 03 04:14 PM
Hutchinson Michael DamonChief Legal OfficerDec 15 '23Option Exercise0.002,25402,254Dec 19 04:28 PM
Shvartsburg AlexCFODec 15 '23Option Exercise0.0061309,548Dec 19 04:16 PM